Soluble Guanylate Cyclase Stimulator class drugs
1 result
Verquvo (vericiguat)
(vericiguat)Merck Sharp & Dohme LLC
Usage: VERQUVO® is indicated for reducing the risk of cardiovascular death and heart failure hospitalization in adults with symptomatic chronic heart failure and an ejection fraction less than 45%, particularly after hospitalization for heart failure or the need for outpatient IV diuretics.